Thrombospondin-1 expression in oral squamous cell carcinomas: Correlations with tumor vascularity, clinicopathological features and survival

Oral Oncology

Volumn 36, Issue 6, 2000, Pages 539-544

  Yao, L ^a   Zhao, Ying Luan ^a   Itoh, S ^a   Wada, S ^a   Yue, L ^a   Furuta, I ^a  

^a TOYAMA MEDICAL AND PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Immunohistochemistry; Microvessel density; Oral squamous cell carcinomas (SCCs); Thrombospondin 1

Indexed keywords

THROMBOSPONDIN 1;

ANGIOGENESIS; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MOUTH CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH;

ANGIOGENESIS INHIBITORS; CARCINOMA, SQUAMOUS CELL; HUMAN; IMMUNOHISTOCHEMISTRY; MICROCIRCULATION; MOUTH NEOPLASMS; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; THROMBOSPONDIN 1; TUMOR MARKERS, BIOLOGICAL;

EID: 0033794962     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(00)00048-8     Document Type: Article

References (24)

1. Thrombospondin as a mediator of cancer cell adhesion in metastasis
2. Thrombospondins; structure and regulation of expression (published erratum appears in FASEB Journal 1993;7:237)
3. The functions of thrombospondin and its involvement in physiology and pathophysiology
4. High level thrombospondin 1 expression in two NIH 3T3 cloned lines confers serum-and anchorage-independent growth
5. Thrombospondin, a potentiator of tumor cell metastasis
6. Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines
7. Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis
8. Peptides from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity
9. Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin-binding domain and synthetic peptides from the type I repeats of thrombospondin
10. Thrombospondin-1 expression in bladder cancer; association with p53 alterations, tumor angiogenesis, and tumor progression
11. Thrombospondin I and II messenger RNA expression in lung carcinoma; relationship with p53 alterations, angiogenic growth factors, and vascular density
12. Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas
13. Thrombospondin 2 expression is correlated with inhibition of angiogenesis and metastasis of colon cancer
14. Methodological study of histologic classification and grading of malignancy in oral squamous cell carcinoma
15. Immunohistochemical detection of thrombospondin-1 in formlin-fixed, paraffin-embedded tissue
16. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma
17. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck
18. Tumor angiogenesis and prognosis in squamous cell carcinoma of the head and neck
19. Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal hyperplastic, and neoplastic human breast
20. Thrombospondin-induced attachment and spreading of human squamous carcinoma cells
21. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin
22. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1